Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells

Antiviral Research

Volumn 140, Issue , 2017, Pages 13-17

  Ghezzi, Silvia ^a   Cooper, Lynsay ^b   Rubio, Alicia ^a   Pagani, Isabel ^a   Capobianchi, Maria Rosaria ^c   Ippolito, Giuseppe ^c   Pelletier, Julien ^b,d   Meneghetti, Maria Cecilia Z ^e   Lima, Marcelo A ^e,f   Skidmore, Mark A ^b,f   Broccoli, Vania ^g   Yates, Edwin A ^b,e,f   Vicenzi, Elisa ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b KEELE UNIVERSITY   (United Kingdom)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

^g CNR   (Italy)

Author keywords

Cell death; Heparin; Neural progenitor cells; Zika virus (ZIKV)

Indexed keywords

ANTIVIRUS AGENT; CASPASE 3; HEPARIN; NESTIN; TRANSCRIPTION FACTOR SOX2;

APOPTOSIS; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL CULTURE; CELL DEATH; CELL SELF-RENEWAL; CYTOPATHOGENIC EFFECT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTON NUCLEAR MAGNETIC RESONANCE; VIRUS REPLICATION; ZIKA FEVER; DRUG EFFECTS; DRUG REPOSITIONING; PATHOGENICITY; PATHOLOGY; VIROLOGY; ZIKA VIRUS;

CELL DEATH; CYTOPATHOGENIC EFFECT, VIRAL; DRUG REPOSITIONING; HEPARIN; HUMANS; NEURAL STEM CELLS; ZIKA VIRUS;

EID: 85009423813     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2016.12.023     Document Type: Article

References (32)

1. Baba, M., Pauwels, R., Balzarini, J., Arnout, J., Desmyter, J., De Clercq, E., Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. U. S. A. 85 (1988), 6132–6136.
2. Bayless, N.L., Greenberg, R.S., Swigut, T., Wysocka, J., Blish, C.A., Zika virus infection induces cranial neural crest cells to produce cytokines at levels detrimental for neurogenesis. Cell Host Microbe 20 (2016), 423–428.
3. Bell, T.M., Field, E.J., Narang, H.K., Zika virus infection of the central nervous system of mice. Arch. Gesamte Virusforsch 35 (1971), 183–193.
4. Caldwell, M.A., Garcion, E., terBorg, M.G., He, X., Svendsen, C.N., Heparin stabilizes FGF-2 and modulates striatal precursor cell behavior in response to EGF. Exp. Neurol. 188 (2004), 408–420.
5. Cao-Lormeau, V.M., Blake, A., Mons, S., Lastere, S., Roche, C., Vanhomwegen, J., Dub, T., Baudouin, L., Teissier, A., Larre, P., Vial, A.L., Decam, C., Choumet, V., Halstead, S.K., Willison, H.J., Musset, L., Manuguerra, J.C., Despres, P., Fournier, E., Mallet, H.P., Musso, D., Fontanet, A., Neil, J., Ghawche, F., Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387 (2016), 1531–1539.
6. Cheng, F., Murray, J.L., Rubin, D.H., Drug repurposing: New treatments for Zika virus infection?. Trends Mol. Med. 22 (2016), 919–921.
7. Crouch, S.P., Kozlowski, R., Slater, K.J., Fletcher, J., The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J. Immunol. Methods 160 (1993), 81–88.
8. D'Ortenzio, E., Matheron, S., Yazdanpanah, Y., de Lamballerie, X., Hubert, B., Piorkowski, G., Maquart, M., Descamps, D., Damond, F., Leparc-Goffart, I., Evidence of sexual transmission of Zika virus. N. Engl. J. Med. 374 (2016), 2195–2198.
9. Dick, G.W., Epidemiological notes on some viruses isolated in Uganda; yellow fever, rift valley fever, bwamba fever, west nile, mengo, semliki forest, bunyamwera, Ntaya, Uganda S and Zika viruses. Trans. R. Soc. Trop. Med. Hyg. 47 (1953), 13–48.
10. Dick, G.W., Kitchen, S.F., Haddow, A.J., Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46 (1952), 509–520.
11. Foy, B.D., Kobylinski, K.C., Chilson Foy, J.L., Blitvich, B.J., Travassos da Rosa, A., Haddow, A.D., Lanciotti, R.S., Tesh, R.B., Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg. Infect. Dis. 17 (2011), 880–882.
12. Garcez, P.P., Loiola, E.C., Madeiro da Costa, R., Higa, L.M., Trindade, P., Delvecchio, R., Nascimento, J.M., Brindeiro, R., Tanuri, A., Rehen, S.K., Zika virus impairs growth in human neurospheres and brain organoids. Science 352 (2016), 816–818.
13. Hamel, R., Dejarnac, O., Wichit, S., Ekchariyawat, P., Neyret, A., Luplertlop, N., Perera-Lecoin, M., Surasombatpattana, P., Talignani, L., Thomas, F., Cao-Lormeau, V.M., Choumet, V., Briant, L., Despres, P., Amara, A., Yssel, H., Misse, D., Biology of Zika virus infection in human skin cells. J. Virol. 89 (2015), 8880–8896.
14. He, S., Lin, B., Chu, V., Hu, Z., Hu, X., Xiao, J., Wang, A.Q., Schweitzer, C.J., Li, Q., Imamura, M., Hiraga, N., Southall, N., Ferrer, M., Zheng, W., Chayama, K., Marugan, J.J., Liang, T.J., Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection. Sci. Transl. Med., 7, 2015 282ra249.
15. Herold, B.C., Gerber, S.I., Belval, B.J., Siston, A.M., Shulman, N., Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry. J. Virol. 70 (1996), 3461–3469.
16. Katsi, V., Kanellopoulou, T., Makris, T., Nihoyannopoulos, P., Nomikou, E., Tousoulis, D., Aspirin vs heparin for the prevention of preeclampsia. Curr. Hypertens. Rep., 18, 2016, 57.
17. Lavrik, I.N., Caspases: pharmacological manipulation of cell death. J. Clin. Investig. 115 (2005), 2665–2672.
18. Motta, I.J., Spencer, B.R., Cordeiro da Silva, S.G., Arruda, M.B., Dobbin, J.A., Gonzaga, Y.B., Arcuri, I.P., Tavares, R.C., Atta, E.H., Fernandes, R.F., Costa, D.A., Ribeiro, L.J., Limonte, F., Higa, L.M., Voloch, C.M., Brindeiro, R.M., Tanuri, A., Ferreira, O.C. Jr., Evidence for transmission of Zika virus by platelet transfusion. N. Engl. J. Med. 375 (2016), 1101–1103.
19. Musso, D., Roche, C., Robin, E., Nhan, T., Teissier, A., Cao-Lormeau, V.M., Potential sexual transmission of Zika virus. Emerg. Infect. Dis. 21 (2015), 359–361.
20. Nahmias, A.J., Kibrick, S., Inhibitory effect of heparin on herpes simplex virus. J. Bacteriol. 87 (1964), 1060–1066.
21. Olsson, T., Gulliksson, H., Palmeborn, M., Bergstrom, K., Thore, A., Leakage of adenylate kinase from stored blood cells. J. Appl. Biochem. 5 (1983), 437–445.
22. Orellana, D.I., Santambrogio, P., Rubio, A., Yekhlef, L., Cancellieri, C., Dusi, S., Giannelli, S.G., Venco, P., Mazzara, P.G., Cozzi, A., Ferrari, M., Garavaglia, B., Taverna, S., Tiranti, V., Broccoli, V., Levi, S., Coenzyme A corrects pathological defects in human neurons of PANK2-associated neurodegeneration. EMBO Mol. Med. 8 (2016), 1197–1211.
23. Parra, B., Lizarazo, J., Jiménez-Arango, J.A., Zea-Vera, A.F., González-Manrique, G., Vargas, J., Angarita, J.A., Zuñiga, G., Lopez-Gonzalez, R., Beltran, C.L., Rizcala, K.H., Morales, M.T., Pacheco, O., Ospina, M.L., Kumar, A., Cornblath, D.R., Muñoz, L.S., Osorio, L., Barreras, P., Pardo, C.A., Guillain–barré Syndrome associated with Zika virus infection in Colombia. N. Engl. J. Med. 375 (2016), 1513–1523.
24. Rasmussen, S.A., Jamieson, D.J., Honein, M.A., Petersen, L.R., Zika virus and birth defects–reviewing the evidence for causality. N. Engl. J. Med. 374 (2016), 1981–1987.
25. Rusnati, M., Vicenzi, E., Donalisio, M., Oreste, P., Landolfo, S., Lembo, D., Sulfated K5 Escherichia coli polysaccharide derivatives: a novel class of candidate antiviral microbicides. Pharmacol. Ther. 123 (2009), 310–322.
26. Sakurai, Y., Kolokoltsov, A.A., Chen, C.C., Tidwell, M.W., Bauta, W.E., Klugbauer, N., Grimm, C., Wahl-Schott, C., Biel, M., Davey, R.A., Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science 347 (2015), 995–998.
27. Salas, A., Sans, M., Soriano, A., Reverter, J.C., Anderson, D.C., Pique, J.M., Panes, J., Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism. Gut 47 (2000), 88–96.
28. Shukla, D., Spear, P.G., Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Investig. 108 (2001), 503–510.
29. Skidmore, M.A., Kajaste-Rudnitski, A., Wells, N.M., Guimond, S.E., Rudd, T.R., Yates, E.A., Vicenzi, E., Inhibition of influenza H5N1 invasion by modified heparin derivatives. Med. Chem. Commun. 6 (2015), 640–646.
30. Spratte, J., Meyer zu Schwabedissen, H., Endlich, N., Zygmunt, M., Fluhr, H., Heparin inhibits TNF-alpha signaling in human endometrial stromal cells by interaction with NF-kappaB. Mol. Hum. Reprod. 19 (2013), 227–236.
31. Veraldi, N., Hughes, A.J., Rudd, T.R., Thomas, H.B., Edwards, S.W., Hadfield, L., Skidmore, M.A., Siligardi, G., Cosentino, C., Shute, J.K., Naggi, A., Yates, E.A., Heparin derivatives for the targeting of multiple activities in the inflammatory response. Carbohydr. Polym. 117 (2015), 400–407.
32. Vicenzi, E., Canducci, F., Pinna, D., Mancini, N., Carletti, S., Lazzarin, A., Bordignon, C., Poli, G., Clementi, M., Coronaviridae and SARS-associated coronavirus strain HSR1. Emerg. Infect. Dis. 10 (2004), 413–418.